CIA-RDP96-00792R000200650008-7

. SG1A
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7
PAGE: 0004
191
COUNTRY :
(U) CHINA (CH).
SECTION 001 OF 004
*********** THIS IS A COMBINED MESSAGE
SG1A
BODY
SUBJ:
ILIGONG RESEARCH BY CHINA'S PEOPLE S
FIBERATION ARMY (U)
WARNING:
(U) THIS IS AN INFORMATION REPORT, NOT FINALLY EVALUATED
INTELLIGENCE.
DEPARTMENT OF DEFENSE
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7

.
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7
PAGE:0005
*
DOI:
(U) 910410.
SG1A
REQS :
(U)
SOURCE: 1. (U) JOURNAL, DONGFANG QIGONG (DQ) (ORIENTAL SCIENCE
QIGONG), BEIJING, CHINA, NO. 3, 1990, IN CHINESE.
2. (U) NEWSPAPER, JINGJI RIBAO (JR), BEIJING, CHINA, 10 APRIL
1991, IN CHINESE.
3. (U) JOURNAL, QIGONG YU KEXUE (QK) (QIGONG AND SCIENCE),
GUANGZHOU, CHINA, NOS. 3, 4, 9 AND 10, 1990; NO. 4, 1991, IN
CHINESE.
4. (U) JOURNAL, QIGONG ZAZHI (QZ) (QIGONG JOURNAL), HANGZHOU,
CHINA, VOL. 11, NO. 4, 1990, IN CHINESE.
5. (U) JOURNAL, ZHONGGUO QIGONG (ZQ) (CHINESE QIGONG),
QINHUANGDAO, CHINA, NOS. 2 AND 5, 1990, IN CHINESE.
SUMMARY :
(U) THIS REPORT PROVIDES INFORMATION ON RESEARCH
CONDUCTED BY CHINA'S PEOPLE'S LIBERATION ARMY ON THE EFFECTS OF
QIGONG TRAINING AND THERAPY.
TEXT:
1. (U) RESEARCH ON THE PROCESS, METHODS, AND CLINICAL
APPLICATIONS OF QIGONG (STC 3049 0501) AND WAIQI (STC 1120 3049) IS
BEING CONDUCTED BY NINE ORGANIZATIONS OF THE CHINESE PEOPLE'S
LIBERATION ARMY (PLA) (FIELD COMMENT -- QIGONG IS A CHINESE SYSTEM
OF PHYSICAL AND MENTAL EXERCISES PRACTICED WITH THE AIM OF
GENERATING NATURAL THERAPEUTIC ENERGY ..
WAIQI) IS THE APPLICATION OF
THAT ENERGY TO VARIOUS PARTS OF THE BODY BY A QIGONG PRACTITIONER
FOR THERAPEUTIC PURPOSES).
2. (U) RESEARCH INTO THE PROCESS OF QIGONG
A. (U) TITLE -- "EFFECT OF WAIQI WHEN APPLIED TO PRESERVED
BLOOD IN VITRO" (ZQ, NO. 2, 1990, PP. 10 - 12)
- RESEARCHERS -- ((XU)) WUGE (STC 1776 3527 2706), ((LU))
HUAIXIA (STC 6424 2037 7209), ((LE)) SHULING (STC 0519 3219 3781),
((WU)) YANGJING (STC 2976 0111 2533), ((LI)) DAZHI (STC 2621 1129
1807), AND ((WAN)) SUJIAN (STC 8001 5685 1696)
- AFFILIATIONS -- BEIJING MR GENERAL HOSPITAL MEDICAL
LABORATORY AND BEIJING MR QIGONG INSTITUTE (FIELD COMMENT
--
SOURCE DOES NOT INDICATE THE SIX RESEARCHERS' RESPECTIVE
ORGANIZATIONAL AFFILIATIONS).
- CONTENTS -- EXPERIMENTS FOR THIS RESEARCH WERE CONDUCTED
DURING JUNE 1988 AND MARCH 1989.
IN THE JUNE 1988 EXPERIMENTS,
WHEN WAIQI WAS APPLIED TO THE PRESERVED IN VITRO BLOOD OF THE
EXPERIMENTAL GROUP, THERE WAS LESS DECLINE IN RED BLOOD CELLS AND
HEMOCHROME (FIELD COMMENT -- A CHEMICAL COMPONENT OF HEMOGLOBIN) AS
COMPARED WITH THE CONTROL GROUP. IN ADDITION, NO RETICULOCYTES
WERE FORMED IN THE EXPERIMENTAL GROUP. IMPAIRMENT OF LYMPHOCYTES
ALSO DIFFERED MARKEDLY BETWEEN BOTH GROUPS, WITH 12.32 PERCENT
LYMPHOCYTE IMPAIRMENT IN THE EXPERIMENTAL GROUP AND 19.71 PERCENT
LYMPHOCYTE IMPAIRMENT IN THE CONTROL GROUP. FURTHERMORE, RED BLOOD
CELLS AND SERUM SUPEROXIDE DISMUTASE (SOD) LEVELS WERE FOUND TO BE
HIGHER IN THE EXPERIMENTAL GROUP. IN THE LATER TESTS, DAMAGE TO
LYMPHOCYTES DIFFERED WIDELY BETWEEN THE TWO GROUPS, WITH 3.7
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7

CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7
PAGE: 0006
PERCENT LYMPHOCYTE DAMAGE IN THE EXPERIMENTAL GROUP, AND 4.6
PERCENT LYMPHOCYTE DAMAGE IN THE CONTROL GROUP.
B. (U) TITLE -- "BIOLOGICAL REACTION OF COLON BACILLI TO
WAIQI" (ZQ, NO. 2, 1990, PP. 10, 12, 13)
- RESEARCHERS -- XU WUGE, ((LIU)) WEILUN (STC 0491 4850 0243),
((LIU)) YUCHI (STC 0491 3768 3069), LI DAZHI, AND WAN SUJIAN
- AFFILIATIONS -- BEIJING MR GENERAL HOSPITAL MEDICAL
LABORATORY, AND BEIJING MR QIGONG INSTITUTE (FIELD COMMENT
--
SOURCE ERRONEOUSLY CALLED THIS INSTITUTE "THE RESEARCH AND CLINICAL
INSTITUTE"). (FIELD COMMENT -- RESPECTIVE ORGANIZATIONAL
AFFILIATIONS OF EACH RESEARCHER WERE NOT GIVEN IN SOURCE.)
- CONTENT -- EXPERIMENTS WERE CONDUCTED IN JUNE 1988 AND MARCH
1989 IN WHICH WAIQI WAS FOUND TO INHIBIT THE GROWTH OF COLON
BACILLI. IN THE JUNE 1988 TESTS, MAXIMUM GROWTH INHIBITION WAS
OBSERVED FROM THE 3D HOUR OF BACTERIAL GROWTH THROUGH THE 12TH
HOUR; THAT IS, FROM THE ACTIVE PERIOD OF THE BACCILUS' GROWTH
THROUGH ITS PERIOD OF STABLE GROWTH. IN THE MARCH 1989 TESTS, THE
GROWTH OF COLON BACILLUS WAS INHIBITED UNTIL THE 6TH HOUR OF
GROWTH, THE BACILLUS' ACTIVE GROWTH PERIOD.
IN ADDITION, DURING
THE EXPERIMENT, FUSION OF MEMBRANES AND CELL WALLS OF TWO SEPARATE
CELLS WAS OBSERVED. THE CHROMOMETER USED WAS A SERIES I-2-3 (SIC)
MULTIPURPOSE BIOCHEMICAL ANALYZER MADE BY THE BAKER COMPANY, A
UNITED STATES FIRM.
C. (U) TITLE -- "FREQUENCY SPECTROGRAM OF QIGONG THERAPISTS
OBSERVED USING A LASER DEVICE FOR MEASUREMENT OF CAPILLARY BLOOD
FLOW" (ZQ, NO. 5, 1990, PP. 11-12)
- RESEARCHERS AND AFFILIATION -- XU WUGE OF THE BEIJING MR
GENERAL HOSPITAL AND OTHERS.
CONTENT
- CHANGES IN VOLUME OF BLOOD FLOW IN QIGONG
PRACTIONERS WERE MEASURED AT THE LAOGONG XUEWEI (STC 0525 1362 4494
0143) (FIELD COMMENT
THIS REFERS TO A POINT BETWEEN THE SECOND
AND THIRD METACARPAL BONE, WHICH THE TIP OF THE MIDDLE FINGER
TOUCHES WHEN THE FIST IS CLENCHED) USING A LASER DEVICE DESIGNED TO
MEASURE CAPILLARY BLOOD FLOW. THE DEVICE DISPLAYS ITS MEASUREMENT
OF THE VOLUME OF CAPILLARY BLOOD FLOW IN VOLTS. THE AVERAGE PEAK
VOLTAGE MEASURED IN QIGONG PRACTIONERS WAS 1,802 MILLIVOLTS, BUT
THE AVERAGE PEAK VOLTAGE MEASURED IN PERSONS WITH NO TRAINING IN
QIGONG WAS 40 MILLIVOLTS. MOREOVER, DIFFERENCES IN VOLTAGE VARIED
WITH THE METHOD AND STYLE OF QIGONG USED IN THE EXPERIMENTS. THE
HIGHEST VOLTAGES WERE RECORDED IN THOSE PERSONS WHO HAD THE MOST
EXPERIENCE PRACTICING QIGONG. ON AVERAGE, PEAK VOLTAGE WAS
ACHIEVED BY QIGONG PRACTIONERS 4 MINUTES AFTER THEY BEGAN
PERFORMING QIGONG. IN NO CASE DID IT TAKE A PRACTIONER LONGER THAN
8 MINUTES TO REACH PEAK VOLTAGE.
D. (U) TITLE -- "EFFECT OF QIGONG WAIQI ON ELECTROPHORESIS OF
RED BLOOD CELLS IN PATIENTS" (DQ, NO. 3, 1990, PP. 46-47)
- RESEARCHERS AND AFFILIATION -- ( (FENG)) LIDA (STC 7458 3810
6671), ((LI)) YUMIN (STC 2621 3768 2404), ((CHEN)) HAIXIN (STC 7115
3189 9515) OF THE PLA NAVY GENERAL HOSPITAL, SHANGHAI.
CONTENT -- QIQONG PRACTITIONERS APPLIED WAIQI RADIATION FOR 10
MINUTES TO IN VITRO BLOOD SAMPLES TAKEN FROM 108 PATIENTS SUFFERING
FROM TUMORS, DIABETES, AND ISCHEMIA. THE ELECTROPHORETIC VELOCITY
OF RED BLOOD CELLS INCREASED UPON EXPOSURE TO WAIQI RADIATION. IN
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7

CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7
PAGE:0007
95 CASES, THE ELECTROPHORETIC VELOCITY OF THE RED BLOOD CELLS BEGAN
TO RISE AT THE BEGINNING OF THE EXPERIMENT. ALTHOUGH THE MECHANISM
OF THE ACTION OF WAIQI ON CELL ELECTROPHORESIS IS UNCLEAR, WAIQI
HAS PROVED EFFECTIVE IN TREATING TUMORS, DIABETES, AND ISCHEMIA.
WAIQI HAS BEEN FOUND TO BE PARTICULARLY EFFECTIVE IN TREATING RED
BLOOD CELLS THAT HAVE SLOWER ELECTROPHORETIC VELOCITIES.
E. (U) TITLE -- ACTION OF QIGONG WAIQI ON ARTIAL NATRIURETI
POLYPEPTIDE, UREA NITRIDE, AND CREATININE IN DIALYSIS PATIENTS (QK,
NO. 3, 1990, PP. 21-22)
- RESEARCHERS AND AFFILIATION -- ( (WANG)) XIUQING (STC 3769
4423 3237), ((LIU)) CUIHONG (STC 0491 5050 4767), ((ZHAO)) YUNTAO
(STC 6392 0061 3447), ((ZHANG)) ZHAOFU (STC 1728 2507 7450),
((ZHOU)) CHUNHUA (STC 0719 2504 5478) AND ((DONG)) BAO (STC 5516
5508) OF THE PLA NAVY GENERAL HOSPITAL'S DEPARTMENT OF INTERNAL
NEPHROLOGY .
- CONTENT -- TESTS WERE CONDUCTED ON 20 PATIENTS WITH CHRONIC
UREMIA RESULTING FROM RENAL FAILURE. WHEN WAIQI THEREAPY WAS
ADMINISTERED IN CONJUNCTION WITH CONVENTIONAL MEDICAL TREATMENT,
ARTIAL NATRIURETI POLYPETIDE AND UREA NITRIDE LEVELS IN THE
PATIENTS' BLOOD PLASMAS SHOWED MARKED REDUCTIONS, AND PROSTAGLANDIN
LEVELS INCREASED. HOWEVER, CREATININE AND THRONBOXANE LEVELS
SHOWED LITTLE CHANGE.
F. (U) TITLE -- "EFFECT OF QIGONG WAIQI ON PHAGOCYTOSIS OF IN
VITRO HUMAN LEUCOCYTES" (QK, NO. 4, 1991, P. 18)
- RESEARCHERS AND AFFILIATION -- FENG LIDA, ( (CHEN)) SHUYING
(STC 7115 3219 5391) AND ((WANG)) YUNSHENG (STC 3769 0061 3932) OF
THE IMMUNOLOGY CENTER, PLA NAVY GENERAL HOSPITAL, SHANGHAI
- CONTENT -- GENERALLY, APPLIED WAIQI RADIATION WAS FOUND TO
IMPROVE PHAGOCYTOTIC FUNCTION OF IN VITRO WHITE BLOOD CELLS. IN 39
OF THE 50 CASES TESTED, A 9.26 PERCENT IMPROVEMENT IN PHAGOCYTOTIC
FUNCTION OF IN VITRO LEUCOCYTES WAS NOTED. IN THE OTHER 11 CASES,
IMPAIRMENT OF IN VITRO LEUCOCYTE PHYGOCYTOTIC FUNCTION WAS
RECORDED.
G.
(U) TITLE -- "EFFECT OF QIGONG ON FUNCTION OF BLOOD
NEUTROPHILS IN HUMANS" (QZ, VOL. 11, NO. 4, 1990, PP. 171-173)
- RESEARCHER AND AFFILIATION -- ( (XIE)) ZHENCHUAN (STC 6200
2182 1557) OF THE MEDICAL LABORATORY AT THE CHENGDU MR GENERAL
HOSPITAL, CHENGDU (GEOCOORD: 3040N/10404E)
CONTENT -- IMMUNOLOGIC FUNCTION OF NEUTROPHILS IN BLOOD WAS
ENHANCED AS A RESULT OF QIGONG TRAINING.
THE PHAGOCYTOTIC RATE WAS
ABOUT 24 PERCENT FOR THE EXPERIMENT'S CONTROL GROUP, BUT THE
PHAGOCYTOTIC RATE FOR THE EXPERIMENTAL GROUP, WHICH STOOD AT ABOUT
21 PERCENT BEFORE THE EXPERIMENT, ROSE TO ABOUT 38 PERCENT ON THE
30TH DAY OF THE SUBJECTS' QIGONG TRAINING. THE EXPERIMENTAL GROUP
ALSO EXPERIENCED AN INCREASE IN ITS RATE OF POSITIVE CELL REACTION
TO NITROBLUE TETRAZOLIUM TESTS, WHICH ROSE FROM ABOUT 32 PERCENT
BEFORE THE EXPERIMENT TO ABOUT 53 PERCENT ON THE 30TH DAY OF QIGONG
TRAINING. THE CONTROL GROUP HAD A POSITIVE CELL REACTION RATE TO
NITROBLUE TETRAZOLIUM TESTS OF ABOUT 28 PERCENT.
H. (U) TITLE -- "EFFECT OF QIGONG ON HEMODYNAMICS AND BLOOD
RHEOLOGY" (QK, NO. 4, 1990, P. 16)
- RESEARCHERS AND AFFILIATION -- ( (WANG)) XIUFANG (STC 3769
4423 5364) AND ((LUO)) FENG (STC 7482 6912), OF THE PLA AIR FORCE
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7

-
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7
PAGE:0008
HOSPITAL IN LANZHOU (GEOCOORD:3603N/10341E).
- CONTENT -- AFTER UNDERGOING QIGONG TRAINING, SIGNIFICANT
REDUCTIONS WERE NOTED IN THE FOLLOWING HEMODYNAMIC AND BLOOD
RHEOLOGY INDICATORS -- TOTAL CARDIAC OUTPUT, HEART RATE INDEX,
CARDIAC OUTPUT PER MINUTE, AVERAGE SYSTOLIC PRESSURE, AVERAGE
DIASTOLIC PRESSURE, AVERAGE ARTERIAL BLOOD PRESSURE, CARDIAC INDEX,
EFFECTIVE BLOOD VOLUME, AND PULSE RATE.
CONSPICUOUS INCREASES WERE
NOTED IN CAPILLARY SEMI-RENEWAL TIME AND AVERAGE RETENTION TIME.
QIGONG WAS FOUND TO INHIBIT THE SYMPATHETIC NERVOUS SYSTEM, TO
RELAX THE SKELETAL MUSCLES, AND INCREASE CAPILLARY BLOOD FLOW. AS
A RESULT OF INCREASED CAPILLARY BLOOD FLOW, MORE OXYGEN, NUTRIENTS,
AND HORMONES REACH CELLS.
I. (U) OTHER RESEARCH
BEIJING MR QIGONG INSTITUTE AND BEIJING MR GENERAL HOSPITAL
CONDUCTED JOINT RESEARCH ON QIGONG WITH THE PLA ACADEMY OF MILITARY
MEDICINE. (DQ, NO. 3, 1990, PP. 33-34)
3. (U) ANIMAL AND CLINICAL APPLICATIONS OF QIGONG
A. (U) TITLE -- "THE STUDY OF TRAUMATIC PARAPLEGIA IN CANINE
MODEL TREATED BY BAGUA XUN DAO GONG (FIELD COMMENT -- ONE OF THE
TYPES OF QIGONG) (SIC) (ZQ, NO. 5, 1990, PP. 9-11
- RESEARCHERS AND AFFILIATION -- XU WUGE OF THE BEIJING MR
GENERAL HOSPITAL, WAN SUJIAN OF THE BEIJING MR QIGONG INSTITUTE AND
OTHERS.
CONTENT -- TRADITIONALLY, QIGONG HAS BEEN USED WITH FAVORABLE
RESULTS IN CHINA TO TREAT TRAUMATIC PARAPLEGIA. THIS STUDY WAS
LAUNCHED IN EARLY 1990 TO DETERMINE THE EFFECTS OF SHORT-TERM
TREATMENT ON ACUTE CASES OF SPINAL CORD INJURY AND CHANGES INDUCED
BY SUCH TREATMENT IN SPINAL CAPILLARY CIRCULATION.
IN THE
EXPERIMENT, 41 DOGS WERE USED AS SUBJECTS. QIGONG WAS FOUND TO BE
EFFECTIVE IN RESTORING NERVE FUNCTION AND SPINAL CAPILLARY
CIRCULATION, IN HELPING THE DOGS REGAIN LOST WEIGHT, AND AS A
SEDATIVE IN CANINE TRAUMATIC PARAPLEGIA CASES.
B.
(U) TITLE -- "QIGONG TREATMENT OF 56 CASES OF FACIAL
PARALYSIS OF THE PERIPHERAL NERVES" (QK, NO. 10, 1990, P. 25).
RESEARCHERS AND AFFILIATION -- ((REN)) GUANGPING (STC 0117 1639
1627) AND ((TANG)) CHENGPEI (STC 0781 2110 1014) OF THE PHYSICAL
THERAPY LABORATORY, 261ST PLA HOSPITAL.
- CONTENT -- THIS TREATMENT WAS CONDUCTED BETWEEN JANUARY 1987
AND OCTOBER 1989 USING A 220 VOLT CURRENT AND THE APPLICATION OF
WAIQI. OF THE 56 PATIENTS TREATED, 41 COMPLETELY RECOVERED, 8
SHOWED SIGNIFICANT IMPROVEMENT, AND 6 SHOWED MODERATE IMPROVEMENT.
ONE OF THE PATIENTS, HOWEVER, EXPERIENCED NO CHANGE IN CONDITION.
C. (U) TITLE -- "EXAMPLE OF A CURE FOR LONG-TERM DYSURIA
RESULTING FROM TRAUMATIC SPINAL INJURY" (QK, NO. 9, 1990, P. 28)
- RESEARCHERS AND AFFILIATION -- ( (LIU)) RUITING (STC 0491 3843
1656) OF THE CLINIC OF THE PLA AIR FORCE, JINAN MR GENERAL
HEADQUARTERS, JINAN (GEOCOORD: 3640N/11700E).
- CONTENT -- TREATMENT COMBINED BIOLOGICAL HOLOGRAPHIC
ACUPUNCTURE THERAPY (STC 3932 3670 0356 1873 6859 0459 4070 3127)
WITH THE APPLICATION OF WAIQI. WAIQI WAS APPLIED FOR 10-20 MINUTES
TO THE LAOGONG XUEWEI AND ABDOMEN OF THE PATIENT, A 6-YEAR-OLD
GIRL. REMOTE WAIQI WAS APPLIED THE NEXT DAY AS WELL. FOLLOWING
THE TREATMENT, THE PATIENT WAS ABLE TO ELIMINATE 300-500
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7

CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7
PAGE:0009
MILLILITERS OF URINE EVERY 2-3 HOURS UNASSISTED WITH NO RESIDUAL
URINE.
D. (U) TITLE -- "TREATMENT OF STRESS HEADACHE WITH QIGONG"
(ZQ, NO. 5, 1990, PP. 15-16)
- RESEARCHERS AND AFFILIATION -- ((GAO)) ZHENGJIN (STC 7559
2973 0093), ((LIU) GUANGYOU (STC 0491 0342 0645), AND ( (MING))
DEJUN (STC 2494 1795 0193) OF THE 324TH PLA HOSPITAL, CHONGQING
(GEOCOORD: 2934N/10635E).
- CONTENT -- THE CLINIC TREATED THE 28 STRESS HEADACHE
PATIENTS OF THE EXPERIMENTAL GROUP WITH QIGONG AND THE 33 PATIENTS
OF THE CONTROL GROUP WITH WESTERN MEDICINE. THOSE IN THE
EXPERIMENTAL GROUP HAD WAIQI APPLIED DIRECTLY TO THE AFFECTED
AREAS. AFTER THE WAIQI TREATMENT, PATIENTS WERE GIVEN MASSAGE
THERAPY. THE CONTROL GROUP WAS GIVEN PAIN KILLERS, SEDATIVES,
SLEEPING PILLS, AND VITAMIN B TABLETS. AFTER TEN DAYS OF
TREATMENT, THE EXPERIMENTAL GROUP REPORTED 15 CASES OF COMPLETE
CURE, 7 CASES OF MARKED IMPROVEMENT, 5 CASES OF MODERATE
IMPROVEMENT, AND 1 CASE IN WHICH THERE WAS NO CHANGE. THE CONTROL
GROUP REPORTED 6 CASES OF COMPLETE CURE, 8 CASES OF MARKED
IMPROVEMENT, 7 CASES OF MODERATE IMPROVEMENT, AND 12 CASES OF NO
CHANGE.
4. (U) QIGONG THERAPY EQUIPMENT
A. (U) MODEL F2-A MULTIFUNCTIONAL QIGONG THERAPY EQUIPMENT
(JR, 10 APRIL 1991, P. 3)
THIS EQUIPMENT WAS DEVELOPED AND MANUFACTURED BY THE JOINT
CHINA TIANHENG INTERNATIONAL ECONOMIC AND TECHNOLOGY TRADE COMPANY
(STC 0022 0948 1131 5899 0948 7139 4842 3444 2111 5890 6319 2496
0678 0155 4920 0361 0674) (FIELD COMMENT -- LOCATION UNKNOWN) UNDER
THE SUPERVISION OF THE BEIJING MR GENERAL HOSPITAL. THE EQUIPMENT
PROBABLY WILL BE MARKETED COMMERCIALLY AFTER THE MANUFACTURER
OBTAINS PATENT RIGHTS TO THE EQUIPMENT.
THE EQUIPMENT IS DESIGNED
TO GENERATE WAIQI THAT WILL FREE CLOGGED ENERGY CHANNELS, REDUCE
INFLAMMATION, AND RELIEVE PAIN.
THE EQUIPMENT IS ALSO DESIGNED TO
IT
FINE TUNE THE AUTONOMIC NERVOUS SYSTEM AND THE IMMUNE SYSTEM.
IS ESPECIALLY EFFECTIVE IN TREATING ANGIITIS, TUMORS, AND
PSEUDOMYOPIA. IT CAN ALSO BE USED TO TREAT 100 TYPES OF DISEASES,
INCLUDING ARTHRITIS, HYPERTENSION, DIABETES, AND BRONCHITIS. IT
WAS CLINICALLY FOUND TO BE EFFECTIVE IN 96.6 PERCENT OF THE CASES
TREATED.
COMMENTS: (FIELD COMMENTS) -- 1. (U) BASED ON THE NUMBER OF
RESEARCH PROJECTS REPORTED, THE BEIJING MR GENERAL HOSPITAL, THE
BEIJING MR QIGONG INSTITUTE, AND THE PLA NAVY GENERAL HOSPITAL
APPEAR TO BE THE PRIMARY PLA ORGANIZATIONS INVOLVED IN QIGONG
RESEARCH.
THE LEADING RESEARCHERS AT THESE ORGANIZATIONS APPEAR TO
BE XU WUGE OF THE BEIJING MR GENERAL HOSPITAL, WAN SUJIAN OF THE
BEIJING MR QIGONG INSTITUTE, AND FENG LIDA OF THE PLA NAVY GENERAL
HOSPITAL.
2. (U) WITH THE EXCLUSION OF PARAGRAPH 3-I, THE EIGHT STUDIES
PERTAINING TO THE QIGONG MECHANISM CAN BE BROKEN DOWN AS FOLLOWS
--
1) SIX STUDIES RELATED TO QIGONG WAIQI, THREE OF WHICH CONCERN THE
IN VITRO EFFECTS OF WAIQI RADIATION (PARA 2-A, 2-D, 2-F), TWO
CONCERN THE IN VIVO EFFECTS OF WAIQI RADIATION (PARA 2-B, 2-E), AND
ONE CONCERNS WAIQI FROM THE STANDPOINT OF THE QIGONG THERAPIST
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7

CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7
PAGE:0010
(PARA 2-C); 2) TWO STUDIES CONCERNING THE EFFECTS QIGONG TRAINING
HAS ON THE PHYSICAL CONDITION OF QIGONG TRAINEES (PARA 2-G, 2-H).
OVERALL, ONLY A SMALL NUMBER OF IN VITRO STUDIES CONDUCTED CONCERN
QIGONG. OF THE EIGHT STUDIES THAT USED HUMAN SUBJECTS, TWO DEALT
WITH THE EFFECTS OF QIGONG ON THE PHAGOCYTOSIS OF HUMAN
LEUCOCYTES. THE RESEARCH STRESSES THE AFFECT OF QIGONG ON THE
HUMAN IMMUNOLOGICAL SYSTEM.
SG1
A
CONFIDENTIAL
Approved For Release 2003/09/09 : CIA-RDP96-00792R000200650008-7